1.
Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands
2.
Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands